| 摘要 |
Compounds having the following formula (I) or a stereoisomer or a pharmaceutically-acceptable salt thereof, wherein R2 is a monocyclic heteroaryl group, and R1, R3, R4, R5 and R6 are as defined herein, are useful as kinase modulators, including IRAK-4 inhibition. |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
BHIDE, RAJEEV S.;DUNCIA, JOHN V.;HYNES, JOHN;NAIR, SATHEESH K.;PITTS, WILLIAM J.;KUMAR, SREEKANTHA R.;GARDNER, DANIEL S.;MURUGESAN, NATESAN;PAIDI, VENKATRAM REDDY;SANTELLA, JOSEPH B.;SISTLA, RAMESH;WU, HONG |
